Sunitinib's inhibition of vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) signalling impairs endothelial integrity, disrupts vascular repair, and induces hypertension, all of which predispose to both arterial thrombosis and VTE [9]. The gene discussed is VEGFA; the disease is Arterial thrombosis.